SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-172759
Filing Date
2014-04-30
Accepted
2014-04-30 17:06:43
Documents
3
Period of Report
2014-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d716015d8k.htm 8-K 19283
2 EX-99.1 d716015dex991.htm EX-99.1 24994
3 GRAPHIC g716015title2.jpg GRAPHIC 3912
  Complete submission text file 0001193125-14-172759.txt   50986
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 14800071
SIC: 2834 Pharmaceutical Preparations